205 related articles for article (PubMed ID: 23757319)
1. A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.
Siegel AB; Narayan R; Rodriguez R; Goyal A; Jacobson JS; Kelly K; Ladas E; Lunghofer PJ; Hansen RJ; Gustafson DL; Flaig TW; Tsai WY; Wu DP; Lee V; Greenlee H
Integr Cancer Ther; 2014 Jan; 13(1):46-53. PubMed ID: 23757319
[TBL] [Abstract][Full Text] [Related]
2. Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice.
Brandon-Warner E; Eheim AL; Foureau DM; Walling TL; Schrum LW; McKillop IH
Cancer Lett; 2012 Dec; 326(1):88-95. PubMed ID: 22863537
[TBL] [Abstract][Full Text] [Related]
3. Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.
Li WY; Yu G; Hogan RM; Mohandas R; Frye RF; Gumpricht E; Markowitz JS
Clin Ther; 2018 Jan; 40(1):103-113.e1. PubMed ID: 29273470
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of a silybin-phosphatidylcholine complex in dogs.
Filburn CR; Kettenacker R; Griffin DW
J Vet Pharmacol Ther; 2007 Apr; 30(2):132-8. PubMed ID: 17348898
[TBL] [Abstract][Full Text] [Related]
5. A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer.
Lazzeroni M; Guerrieri-Gonzaga A; Gandini S; Johansson H; Serrano D; Cazzaniga M; Aristarco V; Puccio A; Mora S; Caldarella P; Pagani G; Pruneri G; Riva A; Petrangolini G; Morazzoni P; DeCensi A; Bonanni B
Cancer Prev Res (Phila); 2016 Jan; 9(1):89-95. PubMed ID: 26526990
[TBL] [Abstract][Full Text] [Related]
6. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
Flaig TW; Gustafson DL; Su LJ; Zirrolli JA; Crighton F; Harrison GS; Pierson AS; Agarwal R; Glodé LM
Invest New Drugs; 2007 Apr; 25(2):139-46. PubMed ID: 17077998
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites.
Hoh CS; Boocock DJ; Marczylo TH; Brown VA; Cai H; Steward WP; Berry DP; Gescher AJ
J Agric Food Chem; 2007 Apr; 55(7):2532-5. PubMed ID: 17355141
[TBL] [Abstract][Full Text] [Related]
8. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).
Kidd P; Head K
Altern Med Rev; 2005 Sep; 10(3):193-203. PubMed ID: 16164374
[TBL] [Abstract][Full Text] [Related]
9. Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers.
Méndez-Sánchez N; Dibildox-Martinez M; Sosa-Noguera J; Sánchez-Medal R; Flores-Murrieta FJ
BMC Pharmacol Toxicol; 2019 Jan; 20(1):5. PubMed ID: 30635055
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects.
Barzaghi N; Crema F; Gatti G; Pifferi G; Perucca E
Eur J Drug Metab Pharmacokinet; 1990; 15(4):333-8. PubMed ID: 2088770
[TBL] [Abstract][Full Text] [Related]
11. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract][Full Text] [Related]
12. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
13. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
14. Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue.
Lazzeroni M; Petrangolini G; Legarreta Iriberri JA; Pascual Avellana J; Tost Robusté D; Cagnacci S; Macis D; Aristarco V; Bonanni B; Morazzoni P; Johansson H; Riva A
Molecules; 2020 Jun; 25(12):. PubMed ID: 32599946
[TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma.
Brandon-Warner E; Sugg JA; Schrum LW; McKillop IH
Cancer Lett; 2010 May; 291(1):120-9. PubMed ID: 19900758
[TBL] [Abstract][Full Text] [Related]
16. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice.
Cui W; Gu F; Hu KQ
World J Gastroenterol; 2009 Apr; 15(16):1943-50. PubMed ID: 19399925
[TBL] [Abstract][Full Text] [Related]
17. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
18. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review.
Soleimani V; Delghandi PS; Moallem SA; Karimi G
Phytother Res; 2019 Jun; 33(6):1627-1638. PubMed ID: 31069872
[TBL] [Abstract][Full Text] [Related]
19. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
Flaig TW; Glodé M; Gustafson D; van Bokhoven A; Tao Y; Wilson S; Su LJ; Li Y; Harrison G; Agarwal R; Crawford ED; Lucia MS; Pollak M
Prostate; 2010 Jun; 70(8):848-55. PubMed ID: 20127732
[TBL] [Abstract][Full Text] [Related]
20. Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C.
Hawke RL; Schrieber SJ; Soule TA; Wen Z; Smith PC; Reddy KR; Wahed AS; Belle SH; Afdhal NH; Navarro VJ; Berman J; Liu QY; Doo E; Fried MW;
J Clin Pharmacol; 2010 Apr; 50(4):434-49. PubMed ID: 19841158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
